SYNOVIAL SARCOMAS
Clinical trials for SYNOVIAL SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SYNOVIAL SARCOMAS trials appear
Sign up with your email to follow new studies for SYNOVIAL SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized immune cells target advanced sarcoma in major trial
Disease control Recruiting nowThis study is testing a new personalized cell therapy called TBI-1301 for adults with advanced synovial sarcoma, a rare and aggressive cancer. The treatment involves collecting and modifying a patient's own immune cells to target a specific protein (NY-ESO-1) found on their tumor…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE3 • Sponsor: Takara Bio Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope drug enters human testing for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first human study of an experimental oral drug called AOH1996 for patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose and understand how the body processes the drug. Researchers will enrol…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Personalized radiation aims to spare sarcoma patients from Long-Term side effects
Disease control Recruiting nowThis study is testing whether selecting certain patients to receive proton radiation instead of standard X-ray radiation before sarcoma surgery can reduce long-term side effects while maintaining the same treatment effectiveness. For each of the 110 adult participants in Norway, …
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Proton beam trial aims to zap inoperable tumors with higher, safer doses
Disease control Recruiting nowThis study is testing whether a newer type of radiation therapy, called proton beam therapy, can be given at a higher dose to better control inoperable soft tissue sarcomas. The goal is to see if this approach stops tumor growth for at least two years without increasing side effe…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC